NEW: Purdue Pharma has settled with Oklahoma AG for $270M, marking the first significant settlement for a company that faces more than 1,600 cases related to the opioid crisis, according to a person familiar with the matter.
Breaking News Emails
Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.Purdue Pharma has settled with the Oklahoma attorney general for $270 million, marking the first significant settlement for a company that faces more than 1,600 cases blaming it for fueling the opioid crisis, according to a person familiar with the matter.
The company was increasingly concerned about a televised trial in Oklahoma, where charges that it deceptively marketed OxyContin would be on full display in a state hit hard by the opioid crisis. By cutting the deal, Purdue pushed its day of reckoning to the fall when the first trial from the 1,600 cases that have been consolidated in a federal court in Ohio will face a jury.A Purdue representative did not respond to a request for comment about the settlement.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
OxyContin-maker Purdue Pharma reaches opioid settlement with Oklahoma, sources sayPurdue Pharma agreed to settle the state of Oklahoma’s claims its illegal marketing of the Oxycontin painkiller caused financial devastation to local communities, the first accord in a recent wave of lawsuits stemming from the U.S. opioid crisis, according to people familiar with the matter.
Lire la suite »
OxyContin-maker Purdue Pharma reaches opioid settlement with Oklahoma Attorney General: SourceOxyContin-maker Purdue Pharma has agreed to settle a lawsuit by the state of Oklahoma accusing it of helping igniting the nationwide opioid crisis, a person familiar with the matter confirmed to CNBC.
Lire la suite »
Former DEA official now working for Oxycontin maker Purdue PharmaEXCLUSIVE: A former senior DEA official who testified before Congress on the government's efforts to stop the opioid epidemic is now working for Oxycontin maker Purdue Pharma
Lire la suite »
OxyContin maker Purdue reaches $270 million settlement in Oklahoma opioid case: sourcePurdue Pharma LP and members of the wealthy Sackler family that own the OxyConti...
Lire la suite »
OxyContin maker Purdue agrees to settle Oklahoma opioid case: sourcePurdue Pharma LP has agreed to settle a lawsuit by the state of Oklahoma accusin...
Lire la suite »
Purdue Pharma, state of Oklahoma reach settlement in landmark opioid lawsuitAs the first agreement in the current wave of litigation against drug companies, the deal could influence future legal action over the cost of the opioid epidemic.
Lire la suite »
Purdue Pharma Reaches $270 Million Settlement With Oklahoma in Opioid Crisis CasePurdue Pharma and its owners, the Sackler family, have agreed to pay $270 million to resolve claims by the Oklahoma attorney general that the company helped fuel the opioid crisis.
Lire la suite »
Purdue Pharma to settle historic Oklahoma opioid lawsuitPurdue Pharma has agreed to settle a historic lawsuit brought by the Oklahoma attorney general who accused the OxyContin maker of aggressively marketing the opioid painkiller and fueling a drug epidemic that left thousands dead in the state, a source familiar with the case tells CNN.
Lire la suite »
Purdue Pharma to pay over $200 million to settle historic Oklahoma opioid lawsuitPurdue Pharma has agreed to pay over $200 million to settle a historic lawsuit brought by the Oklahoma attorney general who accused the OxyContin maker of aggressively marketing the opioid painkiller and fueling a drug epidemic that left thousands dead in the state, a source familiar with the case tells CNN.
Lire la suite »
Sackler Family Actively Trying to Resolve Purdue Pharma LawsuitsMembers of the Sackler family who own OxyContin maker Purdue Pharmahave become more involved in settlement talks to resolve the company’s share of lawsuits accusing drug makers of helping spark the opioid crisis.
Lire la suite »